273 related articles for article (PubMed ID: 33211709)
1. Density of CD3+ and CD8+ cells in gingivo-buccal oral squamous cell carcinoma is associated with lymph node metastases and survival.
Mukherjee G; Bag S; Chakraborty P; Dey D; Roy S; Jain P; Roy P; Soong R; Majumder PP; Dutt S
PLoS One; 2020; 15(11):e0242058. PubMed ID: 33211709
[TBL] [Abstract][Full Text] [Related]
2. Density and location of CD3
Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J
J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
4. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.
Kwak Y; Koh J; Kim DW; Kang SB; Kim WH; Lee HS
Oncotarget; 2016 Dec; 7(49):81778-81790. PubMed ID: 27835889
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics.
Karpathiou G; Casteillo F; Giroult JB; Forest F; Fournel P; Monaya A; Froudarakis M; Dumollard JM; Prades JM; Peoc'h M
Oncotarget; 2017 Mar; 8(12):19310-19322. PubMed ID: 28038471
[TBL] [Abstract][Full Text] [Related]
6. Role Of Cd8+ Tumour-Infiltrating Lymphocytes In Predicting Regional Lymph Node Metastasis In Lip And Oral Cavity Squamous Cell Carcinoma.
Sukhera ZA; Zafar N; Ara N; Muneer S; Haroon A; Saeed Z
J Ayub Med Coll Abbottabad; 2023; 35(2):288-293. PubMed ID: 37422823
[TBL] [Abstract][Full Text] [Related]
7. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a seven-immune-feature-based prognostic score for oral squamous cell carcinoma after curative resection.
Zhou C; Diao P; Wu Y; Wei Z; Jiang L; Zhang W; Li Z; Ye J; Song X; Wu H; Jiang H; Wang Y; Cheng J
Int J Cancer; 2020 Feb; 146(4):1152-1163. PubMed ID: 31304591
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of immune cells in the tumor microenvironment and peripheral blood of gallbladder carcinoma patients.
Zhang Y; Ma C; Wang M; Hou H; Cui L; Jiang C; Sun J; Qu X
Clin Transl Oncol; 2017 Apr; 19(4):477-488. PubMed ID: 27718154
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.
Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300
[TBL] [Abstract][Full Text] [Related]
11. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma.
Sheu BC; Hsu SM; Ho HN; Lin RH; Torng PL; Huang SC
Cancer; 1999 Oct; 86(8):1537-43. PubMed ID: 10526283
[TBL] [Abstract][Full Text] [Related]
12. Differential infiltration of CD8+ and NK cells in lip and oral cavity squamous cell carcinoma.
Zancope E; Costa NL; Junqueira-Kipnis AP; Valadares MC; Silva TA; Leles CR; Mendonça EF; Batista AC
J Oral Pathol Med; 2010 Feb; 39(2):162-7. PubMed ID: 19754647
[TBL] [Abstract][Full Text] [Related]
13. The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival.
Kilvaer TK; Paulsen EE; Khanehkenari MR; Al-Saad S; Johansen RM; Al-Shibli K; Bremnes RM; Busund LT; Donnem T
Br J Cancer; 2016 May; 114(10):1145-51. PubMed ID: 27167450
[TBL] [Abstract][Full Text] [Related]
14. Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.
Kirilovsky A; Marliot F; El Sissy C; Haicheur N; Galon J; Pagès F
Int Immunol; 2016 Aug; 28(8):373-82. PubMed ID: 27121213
[TBL] [Abstract][Full Text] [Related]
15. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.
Laghi L; Bianchi P; Miranda E; Balladore E; Pacetti V; Grizzi F; Allavena P; Torri V; Repici A; Santoro A; Mantovani A; Roncalli M; Malesci A
Lancet Oncol; 2009 Sep; 10(9):877-84. PubMed ID: 19656725
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma.
Yao Q; Bao X; Xue R; Liu H; Liu H; Li J; Dong J; Duan Z; Ren M; Zhao J; Song Q; Yu H; Zhu Y; Lu J; Meng Q
Medicine (Baltimore); 2017 Apr; 96(17):e6735. PubMed ID: 28445292
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?
Koletsa T; Kotoula V; Koliou GA; Manousou K; Chrisafi S; Zagouri F; Sotiropoulou M; Pentheroudakis G; Papoudou-Bai A; Christodoulou C; Xepapadakis G; Zografos G; Petraki K; Pazarli E; Koutras A; Kourea HP; Bafaloukos D; Chatzopoulos K; Iliadis A; Markopoulos C; Venizelos V; Arnogiannaki N; Kalogeras KT; Kostopoulos I; Gogas H; Fountzilas G
Cancer Immunol Immunother; 2020 Aug; 69(8):1549-1564. PubMed ID: 32303794
[TBL] [Abstract][Full Text] [Related]
18. Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease.
Diem S; Hasan Ali O; Ackermann CJ; Bomze D; Koelzer VH; Jochum W; Speiser DE; Mertz KD; Flatz L
Cancer Immunol Immunother; 2018 Jan; 67(1):39-45. PubMed ID: 28894934
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating CD8
Shimizu S; Hiratsuka H; Koike K; Tsuchihashi K; Sonoda T; Ogi K; Miyakawa A; Kobayashi J; Kaneko T; Igarashi T; Hasegawa T; Miyazaki A
Cancer Med; 2019 Jan; 8(1):80-93. PubMed ID: 30600646
[TBL] [Abstract][Full Text] [Related]
20. Assessment of tumor-associated immune cells in laryngeal squamous cell carcinoma.
Zhou L; Li Y; Gao W; Huangfu H; Wen S; Zhang C; Zhao Q; Dong Z; Qu C; Li G; Wu L; Wang B
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1761-1772. PubMed ID: 31115672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]